Nova Southeastern University
nova.eduTotal trials
78
Active
22
Phase 3
2
Total enrollment
8,296
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| growth factors to help in regeneration | — | — | — | — | — | 1 | |
| Floradapt Intensive GI | — | — | — | — | — | 1 | |
| Etanercept | — | — | — | — | — | 1 | |
| Mifepristone | — | — | — | — | — | 1 | |
| N-Acetyl Cysteine | — | — | — | — | — | 1 |
Next readouts
- 2025-09
- 2026-02-24
- 2026-04
- 2027-06-30
Top conditions
- Depression4
- Low Back Pain3
- Amyotrophic Lateral Sclerosis (ALS)3
- ALS2
- Dysphagia2
- HIV Infection2
- Substance Abuse2
- Gulf War Illness2
Frequently asked questions about Nova Southeastern University
- How many clinical trials does Nova Southeastern University have on ClinicalTrials.gov?
- Nova Southeastern University is listed as the lead sponsor on 78 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Nova Southeastern University's trials are in Phase 3?
- 2 of Nova Southeastern University's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Nova Southeastern University focus on?
- Nova Southeastern University's most-studied conditions on ClinicalTrials.gov are Depression, Low Back Pain, Amyotrophic Lateral Sclerosis (ALS), ALS, Dysphagia.
- When are Nova Southeastern University's next clinical trial readouts?
- Nova Southeastern University has 4 upcoming primary-completion readouts tracked here; the soonest is “TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset”, expected around 2025-09.